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Background: Attentional dysfunctions constitute core cognitive symptoms in schizo-
phrenia, but the precise underlying neurocognitive mechanisms remain to be elucidated.
Methods: In this randomized, double-blind, sham-controlled study, we applied, for the 
first time, a theoretically grounded modeling approach based on Bundesen’s Theory 
of Visual Attention (TVA) to (i) identify specific visual attentional parameters affected in 
schizophrenia and (ii) assess, as a proof of concept, the potential of single-dose anodal 
transcranial direct current stimulation (tDCS; 20  min, 2  mA) to the left dorsolateral 
prefrontal cortex to modulate these attentional parameters. To that end, attentional 
parameters were measured before (baseline), immediately after, and 24 h after the tDCS 
intervention in 20 schizophrenia patients and 20 healthy controls.
results: At baseline, analyses revealed significantly reduced visual processing speed 
and visual short-term memory storage capacity in schizophrenia. A significant stimulation 
condition × time point interaction in the schizophrenia patient group indicated improved 
processing speed at the follow-up session only in the sham condition (a practice effect), 
whereas performance remained stable across the three time points in patients receiving 
verum stimulation. In healthy controls, anodal tDCS did not result in a significant change 
in attentional performance.
Conclusion: With regard to question (i) above, these findings are indicative of a pro-
cessing speed and short-term memory deficit as primary sources of attentional deficits 
in schizophrenia. With regard to question (ii), the efficacy of single-dose anodal tDCS for 
improving (speed aspects of visual) cognition, it appears that prefrontal tDCS (at the set-
tings used in the present study), rather than ameliorating the processing speed deficit in 
schizophrenia, actually may interfere with practice-dependent improvements in the rate of 
visual information uptake. Such potentially unexpected effects of tDCS ought to be taken 
into consideration when discussing its applicability in psychiatric populations. The study 
was registered at http://apps.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00011665.
Keywords: transcranial direct current stimulation, schizophrenia, visual processing speed, visual short-term 
memory, theory of visual attention, dorsolateral prefrontal cortex
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inTrODUCTiOn
Visual attention dysfunctions, ranging from impairments in 
processing speed and visual short-term memory (vSTM) capacity 
to deficient top-down control (1–6), are commonly reported in 
schizophrenia and schizophrenia-spectrum disorders. However, 
the question of the precise neurocognitive mechanisms underly-
ing the difficulties in attention tasks has not yet been resolved 
conclusively. For instance, it remains elusive whether both pro-
cessing speed and working memory (WM) functions are affected 
in schizophrenia (7) or whether slowed encoding processes are 
responsible for the reduced vSTM storage capacity in the respec-
tive attention tasks (2, 8, 9). Likewise, it is not clear whether the 
impaired encoding processes arise from impaired top-down 
controlled distractor inhibition (10–14).
To determine whether these deficits can be attributed to 
losses of specific fundamental attention functions, a theoreti-
cally grounded modeling approach is required that can isolate 
and quantify (potentially compromised) core functions in an 
unconfounded measurement. Such an approach is provided 
by Bundesen’s Theory of Visual Attention [TVA; (15)], which 
already proved valuable for systematically characterizing 
cognitive deficits in diverse neuropsychiatric and neurological 
disorders (16–18). By combining this framework theory with 
simple psychophysical tests of whole- and partial-report of 
briefly presented letters, it is possible to derive independent 
estimates of parameters reflecting the individual efficiency of 
core visual attention functions. Two of these parameters, visual 
processing speed, the rate of information uptake per  second 
(C), and vSTM storage capacity, the maximum number of visual 
objects that can be represented at one time (K), capture gen-
eral capacity aspects of the system; and the top-down control 
parameter (α) describes the system’s (top-down) attentional 
selectivity. The ability of the TVA-based approach to provide 
“process-pure” and independent measures of the various atten-
tion functions has been demonstrated in a range of studies 
revealing disorder-specific patterns of attentional deficits, for 
instance, selective impairment in only one parameter but not 
the others (16, 17). Similarly, in healthy individuals, externally 
induced modulations of the alertness level have been shown 
to specifically increase processing speed, without influencing 
vSTM storage capacity (19). Furthermore, as the tasks do not 
require speeded responses, the parameters can be estimated 
uninfluenced by (e.g., antipsychotic drug-induced) motor side 
effects. Importantly also, unlike most standard neurocognitive 
tests, TVA-based assessment is highly sensitive so that even 
subtle deviations of cognitive performance from the norm can 
reliably be detected (20). Given these advantages, the TVA-
based approach is well suited for the prime purpose of the 
present study: to identify the specific attentional functions that 
are compromised in schizophrenia.
A secondary aim of this study was to investigate whether the 
compromised attentional performance in schizophrenia patients 
can be modulated by means of prefrontal transcranial direct 
current stimulation (tDCS). On a neuronal level, abnormal 
activation patterns within dorsolateral prefrontal cortex (dlPFC) 
attention networks are discussed as the underlying source of these 
attentional impairments (13, 21–25). Accordingly, modulation 
of intrinsic prefrontal networks through tDCS has recently been 
proposed as potential non-invasive and safe treatment option 
for the remediation of cognitive dysfunctions in schizophrenia 
patients (26, 27). tDCS modulates cortical excitability by pass-
ing small direct currents on to the scalp via electrodes with 
anodal and cathodal polarity. While short-term tDCS effects 
are attributed to tonic modulations of the resting membrane 
potential of cortical neurons affecting their firing rates, pro-
longed after-effects are presumed to be controlled by protein 
synthesis-dependent processes at the synaptic level (28–31). 
Preliminary studies already provided promising results regard-
ing the potential of tDCS to remediate cognitive deficits in psy-
chiatric diseases, for example, in patients with major depression 
(18, 32, 33) or alcohol dependence (34). However, with respect 
to schizophrenia, the available evidence is scarce and mixed 
(35, 36): one study applied 20 min of anodal tDCS with 2 mA to 
the left dlPFC and could not show that anodal tDCS improves 
performance on a procedural learning task in the whole sample, 
but still had a beneficial effect in a subgroup of patients (37). 
Another single-session experiment reported a positive effect of 
2 mA anodal, but not 1 mA or sham, tDCS to the left dlPFC on 
a WM task, 20 and 40 min after stimulation (38). By contrast, 
in another study, a similar stimulation protocol was shown to 
be ineffective to influence cognitive functions measured by the 
MATRICS consensus cognitive battery composite score (39). 
To expand our knowledge about the possible efficacy of tDCS 
in schizophrenia, in the second step of this proof-of-principle 
study, we explored whether the modulation of intrinsic networks 
through single-dose tDCS can have a functional significance for 
cognitive, and more specifically, visual attentional processes in 
schizophrenia (40). As anodal tDCS applied to the left dlPFC 
was previously shown to modulate intrinsic fronto-parietal 
networks in healthy humans, the beneficial cognitive effect of 
prefrontal tDCS has been attributed to an increase of the state 
of alertness (41). Consequently, we hypothesized that prefrontal 
tDCS would influence particularly alertness-dependent cogni-
tive processes, such as the speed by which visual stimuli are 
processed (42–44). On the other hand, tDCS could also affect 
other attentional components such as vSTM storage capacity or 
attentional selectivity, subserved, at least partly, by prefrontal 
cortex and its functional and structural connections.
Measures assessing tDCS-induced benefits should be able 
to disentangle the potential effects on different attentional 
component processes subserved by prefrontal cortex (13, 38, 
45, 46). Furthermore, as the effects induced by single-dose tDCS 
are subtle (47, 48), highly sensitive tools are a prerequisite for 
reliably detecting any (likely small) modulations of the various 
cognitive sub-processes. Previous studies using pharmacologi-
cal interventions or cue stimuli have already revealed the high 
sensitivity of TVA parameters even to small manipulations of the 
alertness level (19, 42–44). In this respect, TVA-based paramet-
ric attentional assessment provides, arguably, the best available 
tool for the aims of the present study, to (i) create a meaningful 
“attentional profile” of schizophrenia patients and (ii) to examine 
for (subtle) tDCS-induced changes in attentional functions in 
these patients.
TaBlE 2 | Comparison of demographics and clinical ratings for verum and sham groups.
Schizophrenia patients Healthy controls
Verum Sham p-Value Verum Sham p-Value
Age 33.2 (7.67) 39.9 (9.65) 0.54 30.8 (9.34) 32.6 (7.52) 0.64
Gender (m/f) 4/6 3/7 0.64 5/5 5/5 1.0
Handedness (r/l/a) 9/1/0 9/0/1 0.37 9/1/0 9/1/0 1.0
Education (years) 10.8 (1.93) 10.2 (1.14) 0.41 12.8 (0.42) 12.9 (0.32) 0.56
MWT-B 110.62 (20.6) 103.13 (9.99) 0.38 105.8 (14.48) 118.6 (20.81) 0.13
Duration of illness (years) 7.15 (5.87) 6.56 (5.22) 0.82 – – –
CDSS 5.9 (3.81) 4.5 (2.8) 0.36 – – –
GAF 56.9 (8.17) 62.67 (5.29) 0.09 – – –
CGI 4.2 (0.63) 3.7 (0.48) 0.06 – – –
PANSS score
Positive 13.4 (4.22) 12.0 (3.86) 0.45 – – –
Negative 18.3 (3.89) 16.4 (6.19) 0.42 – – –
General 31.4 (5.74) 29.0 (8.82) 0.48 – – –
Total 63.1 (11.93) 57.4 (18.14) 0.42 – – –
CPZ equivalents 437.5 (244.73) 443.47 (490.26) 0.97 – – –
Antidepressants (y/n) 2/8 5/5 0.35 – – –
Mood stabilizer (y/n) 1/9 0/10 1.0
Data are presented as means ± SDs or frequencies.
MWT-B, German Multiple-Choice Vocabulary Test; CDSS, Calgary Depression Rating Scale for Schizophrenia; GAF, Global Assessment of Functioning Scale;  
CGI, Clinical Global Impression Scale; PANSS, Positive and Negative Syndrome Scale; f, female; m, male; r, right; l, left; a, ambidextrous; CPZ, chlorpromazine.
p-Values refer to a statistical comparison between verum and sham condition within the schizophrenia patient and healthy control group.
TaBlE 1 | Group demographics.
Schizophrenia patients Healthy controls p-Value
Age 36.55 (9.16) 31.7 (8.31) 0.09
Gender (m/f) 13/7 10/10 0.34
Handedness (r/l/a) 18/1/1 18/2/0 0.51
Education (years) 10.5 (1.57) 12.8 (0.37) 0.01
Verbal IQ (MWT-B) 106.88 (16.11) 112.2 (18.64) 0.37
Data are presented as means ± SDs or frequencies.
MWT-B, German Multiple-Choice Vocabulary Test; f, female; m, male; r, right; l, left;  
a, ambidextrous.
p-Values refer to a statistical comparison between the schizophrenia patient and 
healthy control group.
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METHODS
Participants
20 patients with a ICD-10 diagnosis of schizophrenia or 
schizophrenia-spectrum disorder (F20 = 19; F25 = 1), recruited 
from the Department of Psychiatry and Psychotherapy (LMU 
Munich), and the same 20, demographically matched, healthy 
controls that participated in our previous study (18), were 
included in the investigation (see Tables 1 and 2 for demographic 
and clinical data). The diagnoses, according to the WHO ICD-10 
criteria for schizophrenia or schizophrenia-spectrum disorder, 
were made by two clinical psychiatrists of whom one (Alkomiet 
Hasan) is a member of this study group. The period of recruit-
ment lasted from May 2015 until October 2016. The trial ended 
after the target sample size was reached. The sample size was 
estimated from previous experimental studies investigating the 
effect of alertness manipulations on TVA parameters in healthy 
participants (42, 43). Patients were assessed for psychopathologi-
cal symptoms [Positive and Negative Syndrome Scale (PANSS); 
Calgary Depression Rating Scale for Schizophrenia (CDSS)] 
(49, 50), disease severity [Clinical Global Impression Scale 
(CGI)] (51), and functioning [Global Assessment of Functioning 
Scale (GAF)] (52). The clinical rater (Irina Papazova) was not 
involved in any other aspects of the study and had undergone 
extensive training in the use of the scales. Participants with a con-
traindication to tDCS were excluded. Further exclusion criteria 
were an IQ below 86 (German Multiple-Choice Vocabulary Test 
MWT-B) (53), red–green color blindness, and suicidal intent. 
All except one patient received second-generation antipsychotics 
and one patient received an additional first-generation antipsy-
chotic medication. 68% of the patients received antipsychotic 
monotherapy. Furthermore, all patients were clinically stable as 
indicated by the PANSS values (see Table 2).
This study was carried out in accordance with the recom-
mendations of LMU Munich Medical Faculty ethics committee 
with written informed consent from all participants. All par-
ticipants gave written informed consent in accordance with the 
Declaration of Helsinki. The protocol was approved by the LMU 
Munich Medical Faculty ethics committee. Participants were 
monetarily compensated for their participation.
The study was registered at https://www.drks.de (identifier: 
DRKS 00011665) and the WHO international clinical trials 
registry platform.1
Study Protocol
The experiment consisted of four sessions taking place on consecu-
tive days at about the same daytime each. On day 1, participants 
were trained on the respective tasks of the TVA-based assessment. 
On day 2, a baseline TVA-based assessment was conducted (T0) 
1 http://apps.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00011665.
FiGUrE 1 | Flow-chart of the experiments.
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and participants were randomly assigned to either the verum or 
the sham tDCS condition. On day 3, the TVA-based assessment 
(T1) took place straightaway after the tDCS (anodal or sham), and 
on day 4, a follow-up assessment of the attentional parameters 
(T2) was conducted to examine for the consolidation of potential 
tDCS after-effects (see Figure 1).
attentional assessment Based  
on Bundesen’s TVa
Primary outcome measure for attentional functioning was the 
parametric attentional assessment based on Bundesen’s TVA 
(15). Participants were tested at baseline, directly after, and 24 h 
after tDCS intervention (see Figure 1).
Framework of the TVA Approach
Theory of Visual Attention is a comprehensive mathematical 
model of selective attention (15, 54), which conceives of visual 
processing as a parallel competitive race of objects in the visual 
field for representation in a capacity-limited vSTM store (55): 
only those objects that are processed fastest will win the competi-
tion, that is, will be encoded in vSTM and thus become available 
for conscious report. The speed with which an object in the 
display is processed depends on the attentional weight assigned 
to it. Both bottom-up and top-down factors, such as, respectively, 
stimulus saliency and fit with instructed (selection-relevant) 
target features, are crucial determinants of the magnitude of the 
attentional weight allocated an object. Accordingly, only part of 
the objects will be represented within vSTM and can be used for 
further processing and goal-directed actions.
General Method for TVA Whole- and Partial-Report
Experiments took place in a dimly lit experimental laboratory 
at the Psychiatric Clinic of the Ludwig-Maximilians-Universität 
München (LMU Munich). TVA whole- and partial-report tasks 
were completed within one test session lasting about 1  h; task 
order was counterbalanced across participants. Stimuli were 
presented on a 27-inch PC monitor on a black background, with 
a refresh rate of 100 Hz and a resolution of 1,024 × 768 pixel. The 
viewing distance was set to approximately 60 cm. A trial started 
with the presentation of a white central fixation point (diameter: 
1 cm) for 1,000 ms which participants were instructed to fixate 
throughout the whole trial. After 250  ms, red and/or blue let-
ters were briefly flashed on the display with exposure durations 
that were adjusted individually according to a criterion value in 
a pretest. The letters were randomly selected from a predefined 
set (ABCDEFGHJKLMNOPRSTUVWXZ), with a letter never 
appearing repeatedly in one trial. The stimuli display was either 
followed by an empty black screen or a pattern mask consisting of 
a blue-red scattered square (≈1.5° visual angle) visible for 500 ms 
at each stimulus location. The participant was instructed to 
report the letters in any order and without speed stressing. The 
experimenter typed the responses on a keyboard and then initial-
ized the next trial. After each block, a visual performance feedback 
informed the participants about the amount of correctly named 
letters out of all reported ones (in %). To avoid too conservative 
and too liberal responses, participants should aim for correctness 
between 70 and 90%.
TVA-Based Whole Report
On each trial six letters, either all red or blue, appeared on an 
imaginary circle with a radius of 6  cm (5.73° of visual angle) 
around the fixation point (see Figure  2A). Participants had to 
identify and report as many letters as possible.
To find the five adequate exposure durations for a given 
participant a pretest of four blocks à 12 trials was conducted 
prior to the main whole-report task in each test session. Three 
types of trials were used in this pretest: two “easy” trials (i.e., one 
longer and one unmasked trial) and one adjusting trial in which 
initially, the six letters were flashed for 80 ms. If the participant 
could correctly identify at least one letter, exposure durations 
were decreased in steps of 10  ms until the lowest individual 
threshold, for which no letter could be reported anymore, was 
detected. This threshold was used to find an adequate set of 
four additional, longer exposure durations for the subsequent 
whole-report task (e.g., 10, 20, 40, 90, and 200 ms). In these five 
conditions, letters were masked. Additionally, in two unmasked 
conditions, letters were presented in the second shortest and the 
longest exposure duration condition. Consequently, there were 
seven “effective” exposure duration conditions. In unmasked 
trials an afterimage of the display emerges which extends the 
effective exposure durations by a constant duration which 
is defined by parameter μ (given in milliseconds) (56). The 
patient group’s average minimum exposure duration was 21 ms 
(SD =  4.47  ms) and did not differ significantly [t(38) = −1.1, 
p = 0.32] from that of the control group, which was on average 
20 ms (SD = 0 ms).
In total, the whole-report task consisted of 140 trials, separated 
into four blocks of 35 trials. Within each block, each display con-
dition was presented equally often in randomized order. Based 
on the performance in the whole-report task, the individual 
processing capacity aspects reflected by the TVA parameters 
perceptual processing speed C and vSTM capacity K, can be 
FiGUrE 2 | (a) Theory of Visual Attention (TVA) whole-report task procedure. After the presentation of a central fixation circle for 1,000 ms and a brief delay of 
250 ms, six letters are flashed in an imaginary circle either in red or blue font for one of five individually adjusted exposure durations (identified in a pretest). In these 
five exposure duration conditions letters were masked for 500 ms. In two unmasked conditions, letters were presented in the second shortest and the longest 
exposure duration condition. (B) Trial sequence and (C) display types of TVA partial-report task. After the presentation of a central fixation for 1,000 ms and a brief 
delay of 250 ms, one of the 16 possible display types appears for a predetermined individual exposure duration. Following that, presented stimuli (T = target = red 
letters; D = distractor = blue letters) are masked for 500 ms. Adapted according to Gögler (18).
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estimated by mathematical data modeling (57). The probability 
of stimulus identification is modeled by an exponential growth 
function, relating the mean number of reported objects to the 
exposure duration. The use of seven effective exposure durations 
allows a broad depiction of the performance spectrum including 
early and late aspects of participant’s whole-report functions, 
and consequently a reliable model fit of the data. The growth 
parameter reveals the rate at which stimuli are processed 
(measured in visual elements per second; C), and the asymptote 
specifies the maximum number of objects that can be represented 
within vSTM store (K) (see Figure 3). Two further parameters, the 
threshold of conscious perception t0 and the effective additional 
exposure duration in unmasked displays μ, were also estimated 
(and did not differ significantly between groups and were not 
modulated by tDCS). These parameters merely serve the valid 
estimation of the parameters of interest but apart from this, they 
were of no further relevance in the present study.
TVA-Based Partial Report
On each trial either one or two letters (1 target, 2 targets or a 
target plus distractor) were flashed in the corners of an imaginary 
square (located 7.5 cm around the fixation point). If two letters 
were presented on the display, they either appeared in a row or in 
a column, but never diagonally. Participants had to report target 
letters (in red color) only, while ignoring distractors (blue). The 
stimulus arrays (see Figure 2B) appeared in randomized order 
FiGUrE 3 | Whole-report performance of a representative schizophrenia patient (a) and a healthy control participant (B). Mean number of correct letter reports as a 
function of exposure duration. Circles represent observed values (=obs), dashed lines represent the best fits of the observed scores by the applied model 
(pred = predicted). The estimate of visual short-term memory capacity K and processing speed C is indicated by the horizontal and diagonal dashed lines, respectively.
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and stimuli were always masked for 500 ms. The partial-report 
task consisted of 16 conditions (4 single-target T, 8 target plus 
distractor T-D, 4 dual-target conditions T-T), which were coun-
terbalanced across all six blocks (see Figure 2C). A pretest (two 
blocks of 24 trials) was used to determine the individual exposure 
durations of the presented letter(s): first, letters were displayed 
with an initial exposure duration of 80 ms. If participants could 
identify two letters in the dual-target condition, exposure dura-
tion was decreased by steps of 10 ms until they could name, on 
average, one letter per trial correctly, whereas the exposure dura-
tion was increased by steps of 10 ms if they could not identify 
any letter. Exposure duration was kept unchanged, if they could 
identify one of the two target letters. Next, performance at the 
determined exposure duration was verified for the different 
experimental conditions in another turn of 24 trials. An adequate 
performance is denoted by correctly reported letters of 70–90% 
for single target conditions (T) and at least 50% for dual-target 
conditions. Otherwise exposure durations were in- or decreased 
manually by the experimenter and performance was rechecked 
in another turn of 24 trials. The patient group’s average exposure 
duration was 81.5 ms (SD = 32.85) and did not differ significantly 
[t(38) = 0.95, p = 0.38] from those of the control group, that was on 
average 75.33 ms (SD = 27.69). The partial-report task consisted 
of 288 trials separated into six blocks of 48 trials. From the prob-
ability of stimulus identification, attentional weights are derived 
for targets (wT) and distractors (wD). Parameter α is defined 
as the ratio of distractor to target weights (wD/wT) and reflects 
top-down efficacy, i.e., the ability to prioritize task-relevant over 
task-irrelevant information. Values of α close to 0 indicate a 
high selectivity, i.e., targets receive more weight than distractors. 
Values of α close to 1 signify no selection and values larger than 1 
imply that distractors receive more weight than targets, and hence 
were seen more easily.
Transcranial Direct Current Stimulation
Transcranial direct current stimulation was delivered by a 
CE-certified stimulator (neuroConn, Germany) through 
saline-soaked surface sponge electrodes (35  cm2) at 2  mA for 
20 min (plus 15 s fade-in and fade-out). The anode was placed 
above the left dlPFC located via F3 (EEG 10–20 system). This 
position covers Brodmann areas 8, 9, or 46 on the medial frontal 
gyrus—areas representative of the left dlPFC (58, 59). The cath-
ode was placed above the right supraorbital area (FP2). This is 
the standard electrode montage used in physiological studies 
(60), and also in behavioral studies, this electrode montage was 
reported to modulate cognition both in healthy humans and 
patients (32, 38, 41).
Based on previous publications, sham stimulation was 
performed in the same way as verum stimulation, but the cur-
rent was applied only for 30  s (plus 15  s fade-in and fade-out) 
(61, 62). Participants were randomly assigned to verum or sham 
tDCS by a computer-generated randomization list.2 To ensure 
double-blindness of both participants and experimenter, the 
experimenter did not have access to this list during the study; 
moreover, tDCS was performed by investigators not otherwise 
involved in the examination of patients. The study was designed 
as a parallel trial: 10 patients received verum left-anodal tDCS, 
and the remaining 10 patients underwent sham tDCS. Similarly, 
10 healthy control participants received verum tDCS and 10 
healthy controls received sham tDCS. During the stimulation, 
participants were not performing any task. This “offline” protocol 
was chosen as we were mainly interested in tDCS after-effects on 
attentional functions—both immediate and longer lasting ones 
of potential clinical relevance. Potential tDCS-induced adverse 
effects were examined by a post hoc comfort rating scale filled in 
by the participants (63).
Data analysis
Data were analyzed using IBM SPSS 22. The alpha level was set 
to 0.05. Baseline group differences in demographic and clinical 
variables were analyzed using independent t-tests for continuous 
variables and χ2 tests or, where appropriate, Fisher’s exact tests, 
2 https://www.random.org/lists/.
TaBlE 3 | Theory of Visual Attention whole- and partial-report parameters at 
baseline for the schizophrenia patient and healthy control group.
Schizophrenia patients Healthy Controls p-Value
M SD M SD
C 29.55 21.21 43.86 19.18 0.03
K 3.01 0.78 3.67 0.94 0.02
α 0.35 0.18 0.36 0.22 0.93
C, visual perceptual processing speed (elements/s); K, visual short-term memory 
capacity (number of elements); α, efficiency of top-down control. p-Values refer to a 
statistical comparison between the schizophrenia patient and healthy control group.
7
Gögler et al. Influence of tDCS on Attention in Schizophrenia
Frontiers in Psychiatry | www.frontiersin.org November 2017 | Volume 8 | Article 259
for categorical variables. Baseline group differences in attentional 
performance as well as baseline differences in attentional perfor-
mance, demographic, and clinical characteristics (patients) in 
participants assigned to the verum versus sham tDCS conditions 
within these two groups were analyzed by independent t-tests. 
Cohen’s d was calculated as a measure of the effect size for the 
group differences in attentional performance (64). To assess 
immediate and enduring effects of tDCS on the attentional 
parameters, two-way mixed ANOVAs were performed with 
time point (T0, T1, T2) as within-subject factor and stimulation 
condition (verum versus sham tDCS) as between-subjects factor, 
separately for the healthy control and the schizophrenia patient 
group. Mauchly’s test of sphericity was used to test the assumption 
of sphericity and, if significant, we applied Huynh–Feldt correc-
tion. In case of a significant interaction, the data were tested for 
simple main effects of time point, that is, we assessed differences 
in attentional parameters between time points for each level of the 
between-subjects factor stimulation condition.
By means of χ2 tests, we assessed whether the number of 
participants who believed to have received verum stimulation 
differed between the verum and sham conditions. Furthermore, 
comfort ratings were compared between participants of the 
verum and sham conditions through independent t-tests.
rESUlTS
All schizophrenia patients and healthy control participants 
completed the entire experiment. No unexpected adverse effects 
of tDCS, such as skin burns, pain, or headache, were reported or 
revealed by the comfort rating questionnaire.
Demographic and Clinical Characteristics
The schizophrenia patient and healthy control groups were 
matched according to age (p  =  0.09), gender (p  =  0.34), IQ 
(p = 0.37), and handedness (p = 0.51). The two groups differed 
significantly with respect to education level (p < 0.01). In both 
groups, participants receiving verum and sham stimulation did 
not differ significantly with respect to any of the demographic and 
clinical characteristics (all ps ≥ 0.06; Table 2).
Baseline Task Performance—Healthy 
Control versus Schizophrenia  
Patient Group
Whole-Report Results
In Figure 3, the mean number of correct reports as a function of 
the (effective) exposure duration is depicted for one representa-
tive schizophrenia patient and one healthy control participant. 
The curves represent the maximum likelihood fits to the observed 
data, which correlated fairly well. TVA’s best fits accounted for 
r2 = 92% of the variance of the observed mean scores at the differ-
ent exposure durations. Based on mathematical data modeling of 
the performance (correct letter reports) in the whole-report task 
(57), individual estimates were derived for perceptual processing 
speed C and vSTM storage capacity K. Table 3 depicts all means 
and SDs of the respective baseline TVA parameters in the healthy 
controls and schizophrenia patients.
Perceptual Processing Speed C
Analysis revealed processing speed to be significantly lower in 
schizophrenia patients (M  =  29.55 items/s, SD  =  21.22) than 
in healthy controls [M = 43.86 items/s, SD = 19.18; t(38) = 2.24, 
p = 0.03] (see Figure 4). This effect is also illustrated by the slope of 
the whole-report functions depicted in Figure 3, which is steeper 
for the representative control participant than for the schizophrenia 
patient. Thus, the rate of visual information uptake within a given 
unit of time is significantly reduced in schizophrenia. Computation 
of Cohen’s d yielded a medium to large effect size (d = 0.7) and a 
43% non-overlap of the two distributions of C scores.
vSTM Capacity K
Analysis disclosed vSTM storage capacity to be significantly 
decreased in schizophrenia patients (M = 3.01, SD = 0.78 items) 
compared to healthy controls [M = 3.67, SD = 0.94 items; t(38) = 2. 
42, p = 0.02] (see Figure 4). As can be seen from Figure 3, as 
exposure duration increases, report performance approaches an 
asymptotic level, which represents the (depicted individuals’) 
vSTM storage capacity: the patient’s asymptote is lower than that 
of the healthy control participant—illustrating that the mean 
number of items that can be represented in vSTM is reduced in 
schizophrenia. The effect size is large (d = 0.8), with a 47.4% non-
overlap of the two distributions of K scores.
Partial-Report Results
Mathematical modeling of performance in the partial-report 
task permits inferences to be drawn about the functioning of 
attentional selectivity, reflected in the top-down control param-
eter α (57). There was again a close correspondence between the 
observed performance at the different exposure durations and 
TVA’s best fits to the data: the predicted values accounted for 
r2 = 91% of the variance of the observed mean scores.
Top-Down Control α
Analysis revealed statistically comparable estimates of top-down 
control α between schizophrenia patients (M = 0.35, SD = 0.18) 
and healthy controls [M = 0.36, SD = 0.22; t(38) = 0.09, p = 0.93] 
(see Figure 4).
immediate and Enduring Effects of tDCS 
on attentional Parameters
Healthy Controls
For processing speed C, the ANOVA revealed the main effect 
of time point to be significant: processing speed increased 
FiGUrE 4 | Whole- and partial-report results. Mean estimates and SEs for the Theory of Visual Attention parameters processing speed C, short-term memory 
capacity K, and efficiency of top-down control α.
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from baseline to post and then to follow-up test [F(2, 36) =  4.05, 
p = 0.03; see Figure 5]. No other significant effects were obtained 
(all ps ≥ 0.12; for means and SDs, see Table 4). As these are the 
results of our in-house, “historical healthy-control cohort,” we 
refer to Ref. (18) for a more detailed description of the findings.
Schizophrenia Patients
Baseline Comparisons between Verum and Sham Condition
For the schizophrenia patients, analyses revealed no significant 
baseline differences between the verum and sham tDCS condi-
tions for the TVA parameters processing speed C and top-down 
control α (all ts ≤  0.37, all ps ≥  0.30). However, there was a 
significant difference with respect to parameter K: patients in the 
verum condition exhibited a significantly higher vSTM capacity 
(M = 3.39, SD = 0.64 items) than patients in the sham condition 
[M = 2.63, SD = 0.75 items; t(18) = 2.44, p = 0.03]. See Table 4 for 
respective means and SDs.
tDCS Effects on Whole-Report Performance
For processing speed, analysis revealed a significant main effect 
of time point [F(2, 36) = 6.72, p = 0.01] and a significant interac-
tion between tDCS condition and time point [F(1.64, 29.44) = 3.67, 
p = 0.04] in the patient group. Separate ANOVAs computed for 
the two tDCS conditions (to follow up the interaction) revealed 
the effect of time point to be significant for the sham group [F(1.41, 
12.67) = 6.48, p = 0.02]: processing speed C increased somewhat 
from the baseline (M = 27.73, SD = 25.69 items/s) to the post test 
(M = 39.02, SD = 41.92 items/s), yielding a trend-level difference 
[t(9) = −2.04, p = 0.07]; and there was a further increase to the 
follow-up test, manifesting in a statistically reliable difference 
between the baseline and follow-up tests [M = 46.01, SD = 44.91 
items/s; t(9) = −2.87, p = 0.02] (see Figure 5). On average, patients 
receiving sham stimulation could process some 18 elements/s 
(67%) more at the follow-up compared to the baseline test. 
A Cohen’s d of 0.50 indicated a medium effect size. In contrast 
to the sham group, there was no main effect of time point for the 
verum group [F(2, 18) = 0.69, p = 0.51], that is, processing speed C 
remained stable across the various time points of testing. At the 
single-subject level, only a single patient (out of 10) in the verum 
condition showed an increase in the parameter processing speed 
C from baseline to follow-up testing considering a threshold 
of ≥50% improvement. In contrast, 7 out of 10 patients in the 
sham condition showed an increase in processing speed (≥50%) 
from baseline to follow-up testing. A Fisher’s exact test between 
tDCS condition (sham/verum) and “improvement ≥50%” (yes/
no) yielded a significant association between tDCS condition and 
“improvement,” p = 0.02.
For the parameter vSTM storage capacity K, analysis yielded 
a significant main effect of time point [F(2, 36) = 4.87, p = 0.01]: 
the patients’ ability to represent items in vSTM increased from 
baseline to post and further to follow-up test. However, the 
time point  ×  tDCS condition interaction was not significant 
[F(2, 36) = 1.36, p = 0.27].
tDCS Effects on Partial-Report Performance
For the parameter top-down control α, analysis yielded no statis-
tically reliable effects (all ps ≥ 0.56).
We repeated these analyses using “GAF” and “CGI” as covari-
ates, which confirmed the results for all three parameters and, 
therefore, indicate that the observed tDCS effect in the schizo-
phrenia patient group cannot be explained by differences in these 
clinical characteristics between the verum and sham condition.
integrity of Blinding and Comfort rating
Participants were successfully blinded: of the schizophrenia 
patients, 9 patients in the verum and 7 in the sham condition 
indicated that they had received verum stimulation [χ2(1) = 1.25, 
p = 0.26]. Of the healthy controls, seven participants in the verum 
and three in the sham condition believed that they had received 
verum stimulation [χ2(1) =  3.20, p =  0.07]. Within both the 
schizophrenia patient and the healthy control group, there were 
no significant differences between participants in the verum and 
sham conditions with respect to comfort ratings (sum score of the 
10-point Likert scales) relating to the time during and after the 
stimulation (all ts ≤ 2.01, all ps ≥ 0.06).
DiSCUSSiOn
The present study had two objectives. First, we applied math-
ematical data modeling based on Bundesen’s TVA to isolate 
TaBlE 4 | Theory of Visual Attention whole- and partial-report parameters in the 





M SD M SD M SD
Healthy controls
C Verum 38.59 16.76 41.53 17.11 46.18 19.92
Sham 49.13 20.84 54.69 22.49 56.09 28.29
K Verum 3.47 0.82 3.33 0.84 3.48 0.78
Sham 3.88 1.04 3.86 0.93 4.01 1.02
α Verum 0.27 0.20 0.22 0.26 0.33 0.16
Sham 0.45 0.21 0.42 0.20 0.39 0.11
Schizophrenia patients
C Verum 31.36 16.83 34.33 19.02 33.92 19.01
Sham 27.73 25.69 39.02 41.92 46.01 44.91
K Verum 3.40 0.64 3.47 0.59 3.64 0.64
Sham 2.63 0.75 3.06 0.69 3.03 0.59
α Verum 0.36 0.15 0.40 0.17 0.42 0.27
Sham 0.34 0.21 0.38 0.18 0.36 0.13
tDCS, transcranial direct current stimulation; C, visual perceptual processing speed 
(elements/s); K, visual short-term memory capacity (number of elements); α, efficiency 
of top-down control.
FiGUrE 5 | Effects of transcranial direct current stimulation (tDCS) on mean perceptual processing speed C in healthy controls (a) and schizophrenia patients (B). 
Processing speed was assessed at baseline (T0), directly after tDCS (T1), and 24 h after tDCS (T2). Error bars represent SEMs.
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the particular attentional deficits in schizophrenia patients 
compared to healthy controls. Second, we assessed whether these 
deficits could be modulated by means of a single, 20-min tDCS 
session with 2 mA over the dlPFC. In brief, we found an altered 
pattern of attentional parameters, expressed by significantly 
reduced visual processing speed C and vSTM storage capacity 
K. However, contrary to our hypothesis, we did not find evi-
dence that verum tDCS, compared to sham stimulation, would 
improve attentional functioning. Instead, a differential develop-
ment from baseline to follow-up assessment indicated that the 
normal, practice-dependent increase in visual processing speed 
that occurs with repeated application of the whole-report task 
(shown by healthy controls and patients in the sham group) 
disappears when verum tDCS is applied to the left dlPFC in 
schizophrenia patients.
Visual Perceptual Slowing and vSTM 
Capacity Deficit at Baseline assessment
To our knowledge, this is the first study applying TVA-based 
parametric attentional assessment in schizophrenia patients. 
This enabled us to isolate an impairment of general attentional 
capacity (without an impairment of attentional selectivity) as the 
primary factor compromising visual attentional functioning in 
schizophrenia. Specifically, at baseline, schizophrenia patients 
exhibited significantly reduced visual processing speed C and 
vSTM storage capacity K. The neural interpretation of the TVA 
(NTVA) (54) attributes processing speed changes to changes in 
either the activation level or the overall number of the neurons 
that are devoted to processing the visual information presented. 
On this notion, our results imply that schizophrenia leads to a 
reduced overall arousal level of the brain, likely owing to changes 
in the excitability of the alertness network. NTVA furthermore 
assumes that vSTM storage relies on a cortical–thalamic cir-
cuitry supporting activity in reverberating loops. Accordingly, 
our finding of schizophrenia patients exhibiting a reduction in 
the amount of information they can maintain in vSTM would 
imply that the functional integrity of this system is impaired.
From a general point of view, our findings are in line with 
previous reports of processing speed and vSTM deficits in schizo-
phrenia revealed by means of various other testing procedures 
(6, 65–67). They also replicate high effect sizes for differences in 
vSTM storage capacity estimates between schizophrenia patients 
and healthy controls based on experimental measures (5, 10, 68). 
However, using the TVA approach, which is based on a well-
grounded computational theory, we could assess relevant and 
distinct attentional components of interest in an independent 
manner—without confounding speed of information uptake, 
vSTM capacity, and distractibility (44, 69, 70). Extracting these 
components within the same tasks with identical stimuli and 
response requirements revealed an attentional profile specific for 
schizophrenia. As selectivity aspects of attention were not sig-
nificantly altered in schizophrenia patients compared to healthy 
controls, we can rule out that the capacity limitations are second-
ary consequences of impaired top-down control. This is again 
in line with previous reports of preserved attentional control of 
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information encoding into short-term memory (11). Note that 
the present results have no bearing with regard to top-down 
controlled processing in situations with (bottom-up) highly sali-
ent distractors. There is evidence that patients with schizophrenia 
exhibit deficits in attentional selection when salient distractors 
compete for attentional selection (12). Furthermore, our results 
are unlikely attributable to unspecific antipsychotic drug-induced 
motor side-effects, as the TVA-based assessment requires only 
unspeeded verbal responses. Similarly, these visual attentional 
deficits are unlikely attributable to eye movement impairments, 
often reported in schizophrenia patients [e.g., Ref. (71)], as the 
TVA-based assessment uses very brief exposure durations below 
the latency of saccadic eye movements. Besides, eye movement 
abnormalities should be reflected in elevated perceptual thresh-
olds (parameter t0). However, this parameter was found to be 
not significantly different between patients and healthy controls. 
The latter also implies that motivational impairments unlikely 
underlie the observed visual attentional deficits.
tDCS-Based Modulation of attentional 
Parameters
Unexpectedly, we found a significant increase in the (impaired) 
parameter processing speed C at the follow-up assessment only 
in patients receiving sham (but not verum) tDCS. That is, single-
session verum tDCS over the dlPFC appears to be ineffective, or 
maybe even harmful, for improving attentional functioning in 
schizophrenia—a finding that echoes those of a recent study (72) 
which assessed the effect of 2-week dlPFC tDCS on the second-
ary outcomes WM (SOPT), processing speed (TMT-A), and 
executive functioning (TMT-B) in schizophrenia patients with 
predominantly negative symptoms. In contrast, in the present 
study, tDCS did not influence information uptake processes 
in healthy control participants. This differential effect of tDCS 
on the processing speed parameter C in healthy participants 
and in those suffering from schizophrenia may be explained 
by unexpected effects of tDCS in schizophrenia. Schizophrenia 
is a disorder of disturbed neuronal plasticity with alterations 
in glutamatergic neurotransmission (73), is characterized by a 
dysfunction in interneurons and GABAergic neurotransmission 
affecting microcircuity (74) and a dopaminergic dysbalance is 
evident (75). tDCS effects are dependent on NMDA, GABA, and 
dopaminergic receptor activity (76) and have been discussed not 
only to act at the soma of pyramidal neurons, but possibly also 
on the interneuron level (77). Due to these alterations that are 
all related to the mode of action of tDCS, one could speculate 
that tDCS may have unexpected clinical and neurophysiological 
effects in schizophrenia patients.
Two potential mechanisms, which cannot be differentiated 
based on our study, might be responsible for the reduction in 
processing speed increase from baseline to follow-up testing. 
First, given that we observed practice-dependent enhancement 
of visual processing speed from baseline to follow-up assessment 
in healthy participants in both the sham and the verum group 
and in schizophrenia patients in the sham group, the applica-
tion of tDCS in schizophrenia patients might interfere with 
practice effects that likely rely on implicit procedural learning 
of performing the whole-report task. Alternatively, tDCS might 
impact processing speed by reducing the overall arousal level in 
schizophrenia patients’ brains for at least 24 h. Thus, for patients 
in the verum group, even though they received the same amount 
of whole-report training as the sham group, the training benefits 
are effectively nulled by the lowered arousal level. The present 
results highlight the need for further safety assessments in tDCS 
studies involving psychiatric patients and, more particularly, for 
more systematic evaluation of tDCS effects on cognition before 
embarking on large-scale clinical trials.
Our results suggest that the applied stimulation parameters—
tDCS for 20 min at 2 mA over the left dlPFC—are not appropriate 
for ameliorating attentional dysfunctions (as assessed by TVA) 
in schizophrenia patients. This appears to be at odds with other 
studies that used similar tDCS protocols and reported beneficial 
effects in reducing negative symptoms and improving cognitive 
functions in schizophrenia (38, 72) and other psychiatric disorders 
(32). Reasons for the unfavorable effects on cognition obtained in 
the present study might be the relatively high intensity and dura-
tion of the stimulation. Although these settings are typical for 
the field of cognitive neuroscience, they have yielded unexpected 
effects in previous tDCS studies of motor cortex, where non-linear 
effects of dosage have been reported with healthy participants: 
greater tDCS intensity, rather than being associated with higher 
efficacy of stimulation, shifted the excitability alterations (78). 
Moreover, the individual response variability of tDCS at both 1 
and 2 mA (79–81) may hamper the efficacy of our intervention in 
the given population offering an alternative explanation of the here 
reported unexpected findings. As the positioning of the electrodes 
can impact tDCS effects (82), our negative finding might also have 
been the result of non-optimal electrode montage: it cannot be 
ruled out that the “reference” electrode over the right supraorbital 
area induced confounding effects and that, for instance, larger 
(being less active) or extracephalic reference electrodes might 
have produced a different outcome. Likewise, although in imaging 
studies this kind of electrode configuration was shown to modu-
late fronto-parietal attention networks (41), the position of the 
“active” electrode above the left dlPFC might have been inappro-
priate for modulating visual attentional functions in schizophrenia 
patients. Finally, it should be borne in mind that schizophrenia 
patients exhibit significant alterations in dopaminergic transmis-
sion and that all antipsychotics act on dopamine receptors. In this 
context, dopaminergic modulation has been shown to impact the 
efficacy of tDCS in a non-linear manner, resulting, for example, in 
a reversal of plasticity effects (83, 84).
limitations
First, the sample size of this proof-of-concept study, while being 
comparable with other studies in the field, was relatively small, 
increasing the probability of a type II error. Therefore, findings 
must be confirmed in a larger sample before generalizing these 
results. The limited sample size and the use of a between-subjects 
design may limit our findings. Albeit not likely, as the patients in 
the verum and sham conditions were comparable with respect 
to the initial visual processing speed parameter, it cannot be 
excluded that the observed tDCS effect may be explained in 
part by differences in sociodemographic characteristics between 
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both groups. Moreover, as all patients received antipsychotic 
medication, cognitive parameters could not be investigated inde-
pendently of potential confounding medication effects. However, 
Pearson correlations between CPZ and cognitive performance (C, 
K, α) at study inclusion did not correlate significantly (C: r = 0.37, 
p = 0.11; K: r = 0.44, p = 0.18; α: r = 0.41, p = 0.08), indicating 
that antipsychotic doses had no impact on our outcome variables. 
Regarding tDCS effects, we cannot rule out that these may have 
resulted from interactions between medication and tDCS yield-
ing the unfavorable outcome. As outlined above, antipsychotic 
drug-induced dopaminergic modulations can affect tDCS-
induced changes in cortical excitability and plasticity (83, 84). 
However, as tDCS is considered an add-on treatment option, 
experimental trials with medicated patients would, arguably, be 
representative for a clinical setting.
Conclusion
In the present study, employing TVA-based parametric assess-
ment of attentional functions, schizophrenia patients were 
revealed to exhibit a characteristic pattern of attentional capacity 
impairments: a significantly reduced rate of visual information 
uptake (per time unit) and a significantly reduced vSTM storage 
capacity (in terms of the number of items that can be maintained 
simultaneously). Combining this approach with a tDCS inter-
vention revealed that 20 min of 2 mA prefrontal tDCS interferes 
with (rather than enhances) practice effects on visual processing 
speed in schizophrenia. This finding of a potential tDCS-induced 
disrupting effect on the here investigated cognitive domain 
calls for further investigation and highlights the need for more 
neuroscience-based research in schizophrenia.
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